Skip to content

Zadroga ActWTC Health ProgramVictim Compensation Fund

Barasch & McGarry Recognizes Prostate Cancer Awareness Month

September 24, 2021 | Michael Barasch

September is Prostate Cancer Awareness Month.

Nearly half a million first responders and people working, living, and studying in Lower Manhattan on or after 9/11 have a dramatically higher risk of developing respiratory illnesses and 68 different types of cancer that are presumed linked to the WTC toxins, including prostate cancer.

Barasch & McGarry represents hundreds of 9/11 community members who have been diagnosed with prostate cancer.

About one in eight men will be diagnosed with prostate cancer during their lifetime.

According to the American Cancer Society, an estimated 248,530 men will be diagnosed with prostate cancer in 2021 – the highest figure for any type of cancer, besides skin cancer.

The major risk factors for prostate cancer are age (six in ten cases are diagnosed in men 65 years-of-age and older), family history, ethnicity (African-American men and Caribbean men of African ancestry have a higher risk), and exposure to toxic chemicals such as Ground Zero toxins.

Early detection of prostate cancer can substantially improve the likelihood of survival.

People with a high risk of prostate cancer should share this information with their primary health care provider and stay alert to the symptoms.  

Common symptoms include difficulty urinating, blood in the urine, and erectile dysfunction.

If you are diagnosed with prostate cancer or any other 9/11-related cancers or respiratory illnesses, we can help you access resources through the free World Trade Center Health Program and the 9/11 Victim Compensation Fund. 

Visit or call 212-385-8000 today.

Leave a Reply

Your email address will not be published. All fields are required

Leave a comment

  • Share this article

  • Newsletter

    Stay updated on breaking 9/11 news
    Subscribe Now

Home Live Chat

Photo of Michael Barasch.
Online Now

Hi, we are here to help if you have questions.